JP2024178310A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024178310A5 JP2024178310A5 JP2024163474A JP2024163474A JP2024178310A5 JP 2024178310 A5 JP2024178310 A5 JP 2024178310A5 JP 2024163474 A JP2024163474 A JP 2024163474A JP 2024163474 A JP2024163474 A JP 2024163474A JP 2024178310 A5 JP2024178310 A5 JP 2024178310A5
- Authority
- JP
- Japan
- Prior art keywords
- alkylene
- nhc
- alkyl
- independently
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962839440P | 2019-04-26 | 2019-04-26 | |
| US62/839,440 | 2019-04-26 | ||
| US201962875169P | 2019-07-17 | 2019-07-17 | |
| US62/875,169 | 2019-07-17 | ||
| US202062978159P | 2020-02-18 | 2020-02-18 | |
| US62/978,159 | 2020-02-18 | ||
| JP2021563605A JP7561141B2 (ja) | 2019-04-26 | 2020-04-10 | カンプトテシン誘導体 |
| PCT/US2020/027831 WO2020219287A1 (en) | 2019-04-26 | 2020-04-10 | Camptothecin derivatives |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563605A Division JP7561141B2 (ja) | 2019-04-26 | 2020-04-10 | カンプトテシン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024178310A JP2024178310A (ja) | 2024-12-24 |
| JP2024178310A5 true JP2024178310A5 (cg-RX-API-DMAC10.html) | 2025-04-03 |
Family
ID=70465562
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563605A Active JP7561141B2 (ja) | 2019-04-26 | 2020-04-10 | カンプトテシン誘導体 |
| JP2024163474A Pending JP2024178310A (ja) | 2019-04-26 | 2024-09-20 | カンプトテシン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021563605A Active JP7561141B2 (ja) | 2019-04-26 | 2020-04-10 | カンプトテシン誘導体 |
Country Status (19)
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| RS64961B1 (sr) * | 2019-04-26 | 2024-01-31 | Immunogen Inc | Derivati kamptotecina |
| CN114845740B (zh) * | 2020-01-31 | 2026-06-02 | 先天制药公司 | 癌症的治疗 |
| US12029736B2 (en) | 2020-02-25 | 2024-07-09 | Mediboston Limited | Camptothecin derivatives and conjugates thereof |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| EP4267140A4 (en) * | 2020-12-23 | 2025-02-26 | Shanghai Ruotuo Biosciences Co., Ltd. | ANTIBODY-DRUG CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS |
| KR20230133312A (ko) * | 2021-01-15 | 2023-09-19 | 알.피.쉐러 테크놀러지즈 엘엘씨 | 캄프토테신 항체-약물 접합체 및 이의 사용 방법 |
| MX2023008341A (es) * | 2021-01-15 | 2023-10-04 | Scherer Technologies Llc R P | Enlazadores de ésteres de doble escisión para conjugados anticuerpo-fármaco. |
| AU2022216696A1 (en) * | 2021-02-05 | 2023-08-17 | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Camptothecin compound, preparation method therefor, and application thereof |
| CN120093941A (zh) * | 2021-02-09 | 2025-06-06 | 苏州宜联生物医药有限公司 | 生物活性物偶联物及其制备方法和用途 |
| US12521444B2 (en) * | 2021-02-25 | 2026-01-13 | Fortvita Biologics Limited | Anti-HER2 antibody-drug conjugates and uses thereof |
| KR20240031235A (ko) * | 2021-05-27 | 2024-03-07 | 자임워크스 비씨 인코포레이티드 | 캄프토테신 유사체, 접합체 및 사용 방법 |
| CA3224492A1 (en) | 2021-07-19 | 2023-01-26 | Xiaojun Han | Immunoconjugates and methods |
| US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
| JP2024532768A (ja) * | 2021-08-19 | 2024-09-10 | ハイナン シムセレ ザイミン ファーマシューティカル カンパニー リミテッド | カンプトテシン誘導体、その薬物組成物およびその応用 |
| EP4393514A1 (en) * | 2021-08-24 | 2024-07-03 | Kunshan Xinyunda Biotech Co., Ltd. | Antibody-drug conjugate conjugated via breakable linker |
| CN117940432B (zh) * | 2021-09-01 | 2025-12-23 | 上海弼领生物技术有限公司 | 一种喜树碱类化合物、其制备方法和用途 |
| EP4460330A1 (en) * | 2022-01-06 | 2024-11-13 | Virtuoso Binco, Inc. | Conjugates, compositions and methods of use |
| WO2023143208A1 (zh) * | 2022-01-26 | 2023-08-03 | 苏州宜联生物医药有限公司 | 一种药物连接体偶联物的制备方法 |
| CA3253220A1 (en) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | ANTIBODIES CONJUGATED FOR TARGETING TUMORS EXPRESSING TROP-2 |
| IL315366A (en) | 2022-03-23 | 2024-11-01 | Synaffix Bv | Antibody pairs for targeting PTK7-expressing tumors |
| US20250205353A1 (en) | 2022-03-23 | 2025-06-26 | Synaffix B.V. | Antibody-conjugates for targeting of tumours expressing nectin-4 |
| MX2024011519A (es) | 2022-03-23 | 2024-09-24 | Synaffix Bv | Conjugados de anticuerpos para el direccionamiento contra tumores que expresan el antigeno carcinoembrionario. |
| KR20240162575A (ko) | 2022-03-25 | 2024-11-15 | 자임워크스 비씨 인코포레이티드 | 엽산 수용체 알파를 표적화하는 항체-약물 접합체 및 사용 방법 |
| EP4514350A1 (en) * | 2022-04-29 | 2025-03-05 | Shanghai MicuRx Pharmaceutical Co., Ltd. | Ligand-drug conjugate of camptothecin analogs, intermediates, preparation method therefor, pharmaceutical composition and application thereof |
| WO2023217227A1 (zh) | 2022-05-12 | 2023-11-16 | 先声再明医药有限公司 | 喜树碱类衍生物及配体-药物偶联物 |
| JP2025515988A (ja) * | 2022-05-13 | 2025-05-23 | シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド | カンプトテシン化合物、その調製方法及びその使用 |
| AU2023278370A1 (en) * | 2022-05-30 | 2025-01-09 | Medilink Therapeutics (Suzhou) Co., Ltd. | Preparation method for drug linker conjugate and intermediate thereof |
| EP4285935A1 (en) * | 2022-06-03 | 2023-12-06 | Emergence Therapeutics AG | Novel anti-nectin-4 antibody camptothecin derivative conjugates |
| CN119630428A (zh) | 2022-07-12 | 2025-03-14 | 西托姆克斯治疗公司 | Epcam免疫缀合物及其用途 |
| CN119486763A (zh) * | 2022-07-14 | 2025-02-18 | 苏州宜联生物医药有限公司 | 抗体药物偶联物及其制备方法和用途 |
| EP4309676A1 (en) * | 2022-07-22 | 2024-01-24 | Emergence Therapeutics AG | Novel anti-nectin-4 antibody camptothecin derivative conjugates |
| WO2024020734A1 (en) * | 2022-07-25 | 2024-02-01 | Immunogen, Inc. | Novel processes for preparing camptothecin derivatives |
| CN117510515A (zh) * | 2022-07-28 | 2024-02-06 | 明慧医药(杭州)有限公司 | 适用于抗体-药物偶联物的毒素分子 |
| WO2024050031A2 (en) * | 2022-08-31 | 2024-03-07 | Bionecure Therapeutics Inc | Novel camptothecin derivatves as antibody-drug conjugates (adc) payloads |
| KR20240035370A (ko) * | 2022-09-08 | 2024-03-15 | 주식회사 피노바이오 | 신규 캄토테신 유도체 및 이를 포함하는 운반체-약물 접합체 |
| TWI876557B (zh) * | 2022-09-30 | 2025-03-11 | 臺北醫學大學 | 用於前列腺癌診斷和早期發病的單株抗體 |
| KR20250079213A (ko) | 2022-10-09 | 2025-06-04 | 라노바 메디신즈 리미티드 | 화합물, 조성물 및 방법 |
| EP4605425A1 (en) * | 2022-10-18 | 2025-08-27 | Zymeworks BC Inc. | Antibody-drug conjugates targeting glypican-3 and methods of use |
| US20260146045A1 (en) * | 2022-10-20 | 2026-05-28 | Solve Therapeutics, Inc. | Compositions and uses thereof |
| KR20250111373A (ko) * | 2022-11-25 | 2025-07-22 | 밍훼이 파마슈티컬 (항저우) 리미티드 | 항종양 화합물 및 이의 응용 |
| CN116712561A (zh) * | 2022-12-29 | 2023-09-08 | 杭州爱科瑞思生物医药有限公司 | 含n-亚甲基酰胺连接子的抗体-药物偶联物 |
| CN116870187A (zh) * | 2022-12-29 | 2023-10-13 | 杭州爱科瑞思生物医药有限公司 | N-氧杂环烷基取代的喜树碱衍生物的抗体偶联药物 |
| CN116712563A (zh) * | 2022-12-29 | 2023-09-08 | 杭州爱科瑞思生物医药有限公司 | N-卤代烷基取代的喜树碱衍生物的抗体偶联药物 |
| CN116253741B (zh) * | 2022-12-30 | 2024-02-02 | 上海禧耀医药科技有限公司 | 一种贝洛替康衍生物的合成方法 |
| WO2024166056A1 (en) * | 2023-02-10 | 2024-08-15 | Pinotbio, Inc. | Linker for antibody-drug conjugate |
| IL322897A (en) * | 2023-02-23 | 2025-10-01 | Phrontline Biopharma Hangzhou Co Ltd | Camptothecin derivatives and conjugates, methods for their preparation and medical uses |
| EP4688787A1 (en) * | 2023-04-07 | 2026-02-11 | Innovent Biologics (Suzhou) Co., Ltd. | Antibody-drug conjugates of camptothecin derivatives and uses thereof |
| AU2024302681A1 (en) * | 2023-06-13 | 2026-01-15 | Chengdu Brilliant Pharmaceutical Co., Ltd. | Camptothecin derivative for treating or preventing cancer, and antibody-drug conjugate thereof |
| IL327670A (en) | 2023-10-11 | 2026-06-01 | Antikor Biopharma Ltd | Antibodies, conjugates, and uses thereof |
| CN122374343A (zh) | 2023-11-30 | 2026-07-10 | 江苏康宁杰瑞生物制药有限公司 | 包含pd-l1结合分子与双特异性抗体-药物偶联物的组合物及其用途 |
| AU2024415931A1 (en) | 2023-12-27 | 2026-07-16 | Jiangsu Alphamab Biopharmaceuticals Co., Ltd. | Multi-specific antibody targeting her3 and trop2 and conjugate thereof |
| CN120058721A (zh) * | 2024-01-08 | 2025-05-30 | 杭州爱科瑞思生物医药有限公司 | 7-氟烷基取代的喜树碱衍生物的制备及其应用 |
| WO2025153001A1 (zh) * | 2024-01-17 | 2025-07-24 | 北京泰德制药股份有限公司 | 含有噻唑[5,4-b]吡啶结构的抗体偶联药物及其用途 |
| WO2025184362A1 (en) * | 2024-02-28 | 2025-09-04 | Macrogenics Inc. | Adam9 antibody-drug conjugates |
| WO2025199665A1 (en) * | 2024-03-23 | 2025-10-02 | Ranok Therapeutics (Hangzhou) Co. Ltd. | Methods and compositions for targeted protein degradation |
| TW202615101A (zh) * | 2024-06-06 | 2026-04-16 | 德商拜恩技術股份公司 | Ca19-9結合分子 |
| CN119101060B (zh) * | 2024-06-13 | 2025-10-31 | 天津中医药大学 | 喜树碱衍生物及其制备方法和应用 |
| WO2026085745A1 (en) * | 2024-10-23 | 2026-04-30 | Zai Lab (Shanghai) Co., Ltd. | Dosing regimens of antibody-drug conjugate targeting delta-like ligand 3 for treatment of neuroendocrine neoplasms |
| CN119350434B (zh) * | 2024-12-24 | 2025-04-29 | 苏州共康医药科技有限公司 | 一种可切割连接子Ala-Ala-Ala的工艺合成方法 |
| WO2026156672A1 (zh) * | 2025-01-24 | 2026-07-30 | 岩唐生物科技(杭州)有限责任公司 | 偶联物及其制备方法和应用 |
| WO2026161794A1 (en) | 2025-01-27 | 2026-07-30 | Cytomx Therapeutics, Inc. | Epcam immunoconjugates and therapeutic uses thereof |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| US5559235A (en) * | 1991-10-29 | 1996-09-24 | Glaxo Wellcome Inc. | Water soluble camptothecin derivatives |
| DK0540099T3 (da) * | 1991-10-29 | 1996-06-17 | Glaxo Wellcome Inc | Vandopløselige camptothecinderivater |
| EP0563475B1 (en) | 1992-03-25 | 2000-05-31 | Immunogen Inc | Cell binding agent conjugates of derivatives of CC-1065 |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US20080152586A1 (en) | 1992-09-25 | 2008-06-26 | Avipep Pty Limited | High avidity polyvalent and polyspecific reagents |
| US6355780B1 (en) | 1995-02-22 | 2002-03-12 | Yeda Research And Development Co. Ltd. | Antibodies to the death domain motifs of regulatory proteins |
| DE19640207A1 (de) | 1996-09-30 | 1998-04-02 | Bayer Ag | Glycokonjugate von modifizierten Camptothecin-Derivaten (A- oder B-Ring-Verknüpfung) |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| HK1049997B (en) | 1999-11-24 | 2007-02-23 | Immunogen, Inc. | Cytotoxic agents comprising taxanes and their therapeutic use |
| US6268375B1 (en) | 1999-12-29 | 2001-07-31 | Research Triangle Institute | 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase I inhibition |
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| US6855720B2 (en) * | 2001-03-01 | 2005-02-15 | California Pacific Medical Center | Nitrogen-based camptothecin derivatives |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| US6716821B2 (en) | 2001-12-21 | 2004-04-06 | Immunogen Inc. | Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same |
| US8877901B2 (en) | 2002-12-13 | 2014-11-04 | Immunomedics, Inc. | Camptothecin-binding moiety conjugates |
| US6756397B2 (en) | 2002-04-05 | 2004-06-29 | Immunogen, Inc. | Prodrugs of CC-1065 analogs |
| EP1534674A4 (en) | 2002-08-02 | 2007-11-28 | Immunogen Inc | CYTOTOXIC AGENTS CONTAINING NEW, EFFECTIVE TAXANES AND THEIR THERAPEUTIC USE |
| EP1542723B1 (en) | 2002-08-16 | 2011-02-23 | ImmunoGen, Inc. | Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| DK1578446T3 (en) | 2002-11-07 | 2015-06-29 | Immunogen Inc | ANTI-CD33 ANTIBODIES AND PROCEDURES FOR TREATING ACUTE MYELOID LEUKEMIA BY USING IT |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| US7276497B2 (en) | 2003-05-20 | 2007-10-02 | Immunogen Inc. | Cytotoxic agents comprising new maytansinoids |
| US7067666B2 (en) | 2003-06-27 | 2006-06-27 | Research Triangle Institute | 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
| CA2556752C (en) | 2004-02-23 | 2016-02-02 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| US7811572B2 (en) | 2005-08-24 | 2010-10-12 | Immunogen, Inc. | Process for preparing purified drug conjugates |
| AU2006213662B2 (en) | 2005-02-11 | 2010-08-05 | Immunogen, Inc. | Process for preparing stable drug conjugates |
| KR101268939B1 (ko) | 2005-07-08 | 2013-05-30 | 유니버시티 오브 취리히 | 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이 |
| WO2007027935A2 (en) | 2005-08-31 | 2007-03-08 | The Regents Of The University Of California | Cellular libraries of peptide sequences (clips) and methods of using the same |
| EP1962961B1 (en) | 2005-11-29 | 2013-01-09 | The University Of Sydney | Demibodies: dimerisation-activated therapeutic agents |
| EP1996612A4 (en) | 2006-03-03 | 2010-10-20 | Univ Kingston | COMPOSITIONS FOR THE TREATMENT OF CANCER |
| PT2032606E (pt) | 2006-05-30 | 2014-02-05 | Genentech Inc | Anticorpos e imunoconjugados e respetivas utilizações |
| CA2655379A1 (en) | 2006-06-22 | 2007-12-27 | Walter And Eliza Hall Institute Of Medical Research | Structure of the insulin receptor ectodomain |
| EP2190861A4 (en) | 2007-08-22 | 2011-03-30 | Univ California | ACTIVE BINDING POLYPEPTIDES AND METHOD FOR THEIR IDENTIFICATION AND USE |
| CA2700391A1 (en) | 2007-09-24 | 2009-04-02 | University Of Zuerich | Designed armadillo repeat proteins |
| NZ588884A (en) | 2008-04-30 | 2013-05-31 | Immunogen Inc | Cross-linkers and their uses |
| UA108598C2 (xx) | 2008-04-30 | 2015-05-25 | Високоефективні кон'югати та гідрофільні зшиваючі агенти (лінкери) | |
| KR101098335B1 (ko) | 2008-07-18 | 2011-12-26 | 성균관대학교산학협력단 | 신코나 기재 이작용성 유기 촉매 및 이를 이용한 메소-고리산무수물의 비대칭 고리 열림 반응을 통한 키랄성헤미에스터의 제조방법 |
| MX2011004550A (es) | 2008-10-31 | 2011-07-20 | Centocor Ortho Biotech Inc | Composiciones de de supercóntigos a base de dominios de fibronectina tipo iii, métodos y usos. |
| EP3543256A1 (en) | 2009-01-12 | 2019-09-25 | Cytomx Therapeutics Inc. | Modified antibody compositions, methods of making and using thereof |
| CN102596992B (zh) | 2009-02-12 | 2015-09-09 | 詹森生物科技公司 | 基于ⅲ型纤连蛋白结构域的支架组合物、方法及用途 |
| CA2784610C (en) | 2009-12-23 | 2020-07-14 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them |
| CN105777907B (zh) | 2010-02-24 | 2020-03-17 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| LT2544719T (lt) | 2010-03-12 | 2019-10-25 | Debiopharm Int Sa | Cd37 surišančios molekulės, ir jų imunokonjugatai |
| HUE029622T2 (en) | 2010-04-30 | 2017-03-28 | Janssen Biotech Inc | Stabilized fibronectin domain compositions, methods and uses |
| JP5828902B2 (ja) | 2010-10-29 | 2015-12-09 | イミュノジェン, インコーポレイテッド | 非拮抗性egfr結合分子およびその免疫複合体 |
| CA2815277A1 (en) | 2010-10-29 | 2012-05-03 | Immunogen, Inc. | Novel egfr-binding molecules and immunoconjugates thereof |
| SI2675480T1 (sl) | 2011-02-15 | 2019-05-31 | Immunogen, Inc. | Metode priprave konjugatov |
| ES2661466T3 (es) | 2011-04-01 | 2018-04-02 | Immunogen, Inc. | Métodos para aumentar la eficacia de la terapia contra el cáncer con FOLR1 |
| EP2524929A1 (en) | 2011-05-17 | 2012-11-21 | Sanofi | Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms |
| US9458170B2 (en) * | 2012-06-18 | 2016-10-04 | Yuliang Li | Compound of camptothecin and preparation and use thereof |
| EP2882844B1 (en) | 2012-08-10 | 2018-10-03 | Cytomx Therapeutics Inc. | Protease-resistant systems for polypeptide display and methods of making and using thereof |
| KR20250051130A (ko) | 2013-09-25 | 2025-04-16 | 싸이톰스 테라퓨틱스, 인크. | 매트릭스 메탈로프로테이나제 기질 및 다른 절단성 모이어티 및 이의 사용 방법 |
| SG10201902571VA (en) | 2013-12-25 | 2019-04-29 | Daiichi Sankyo Co Ltd | Anti-trop2 antibody-drug conjugate |
| EP3628328B1 (en) | 2014-01-31 | 2022-09-14 | Cytomx Therapeutics Inc. | Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof |
| IL300408B2 (en) | 2015-01-20 | 2025-11-01 | Cytomx Therapeutics Inc | Matrix metalloprotease-cleavable and serine protease cleavable substrates and methods of use thereof |
| BR112017023872A2 (pt) | 2015-05-04 | 2018-07-24 | Cytomx Therapeutics Inc | anticorpos anti-cd166, anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos |
| MD3558391T2 (ro) | 2016-12-23 | 2022-05-31 | Immunogen Inc | Imunoconjugate care țintesc ADAM9 și procedee de utilizare a acestora |
| CN111936169A (zh) * | 2018-04-06 | 2020-11-13 | 西雅图遗传学公司 | 喜树碱肽缀合物 |
| RS64961B1 (sr) * | 2019-04-26 | 2024-01-31 | Immunogen Inc | Derivati kamptotecina |
-
2020
- 2020-04-10 RS RS20231182A patent/RS64961B1/sr unknown
- 2020-04-10 SG SG11202110922QA patent/SG11202110922QA/en unknown
- 2020-04-10 KR KR1020217038788A patent/KR20220027828A/ko active Pending
- 2020-04-10 ES ES20722197T patent/ES2966473T3/es active Active
- 2020-04-10 FI FIEP20722197.9T patent/FI3958977T3/fi active
- 2020-04-10 CN CN202080031665.2A patent/CN113766954B/zh active Active
- 2020-04-10 SI SI202030336T patent/SI3958977T1/sl unknown
- 2020-04-10 HU HUE20722197A patent/HUE065484T2/hu unknown
- 2020-04-10 PL PL20722197.9T patent/PL3958977T3/pl unknown
- 2020-04-10 PT PT207221979T patent/PT3958977T/pt unknown
- 2020-04-10 WO PCT/US2020/027831 patent/WO2020219287A1/en not_active Ceased
- 2020-04-10 DK DK20722197.9T patent/DK3958977T3/da active
- 2020-04-10 EP EP23196776.1A patent/EP4316524A3/en active Pending
- 2020-04-10 EP EP20722197.9A patent/EP3958977B1/en active Active
- 2020-04-10 IL IL286846A patent/IL286846B2/en unknown
- 2020-04-10 IL IL317911A patent/IL317911A/en unknown
- 2020-04-10 LT LTEPPCT/US2020/027831T patent/LT3958977T/lt unknown
- 2020-04-10 HR HRP20231619TT patent/HRP20231619T1/hr unknown
- 2020-04-10 AU AU2020263231A patent/AU2020263231B2/en active Active
- 2020-04-10 CN CN202411268191.XA patent/CN119119176A/zh active Pending
- 2020-04-10 JP JP2021563605A patent/JP7561141B2/ja active Active
- 2020-09-25 US US17/032,219 patent/US11229639B2/en active Active
-
2021
- 2021-10-15 US US17/502,806 patent/US20220133711A1/en active Pending
-
2024
- 2024-09-20 JP JP2024163474A patent/JP2024178310A/ja active Pending